Xtx Topco LTD Athira Pharma, Inc. Transaction History

Xtx Topco LTD

  • $1.3 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024
BUY
$1.92 - $2.71 $43,574 - $61,503
22,695 New
22,695 $60,000
Q3 2022

Nov 14, 2022
BUY
$2.93 - $3.96 $178,413 - $241,132
60,892 Added 196.53%
91,875 $273,000
Q2 2022

Aug 15, 2022
BUY
$2.74 - $13.43 $84,893 - $416,101
30,983 New
30,983 $94,000

Others Institutions Holding ATHA

# of Institutions
66
Shares Held
16.9M
Call Options Held
112K
Put Options Held
68K
View Full List

About Athira Pharma, Inc.

ATHA Quotes by TradingView
  • Ticker ATHA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 37,817,700
  • Market Cap $25.3M
  • Description
  • Athira Pharma, Inc., a late clinical-stage biopharmaceutical company, focuses on developing small molecules to restore neuronal health and slow neurodegradation. The company's lead product candidate is ATH-1017, a blood brain barrier-penetrating, small molecule HGF/MET positive modulator that is in LIFT-AD Phase 3 and ACT-AD Phase 2 clinical tri...
More about ATHA
Track This Portfolio

Track Xtx Topco LTD Portfolio

Follow Xtx Topco LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Xtx Topco LTD, based on Form 13F filings with the SEC.

News

Stay updated on Xtx Topco LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email